<i>Tubg2</i> mRNA level is decreasing during mouse preimplantation development. by Stanislav Vinopal (190321)

Genes whose expression was decreased by 100 nM ouabain by more than 1.3-fold. by Larisa V. Smolyaninova (3600053)

Sustained expression of radmis results in decreased cell proliferation and increased cell-cycle exit of NSPCs. by Takahito Yumoto (481671)

Point cell model behavior. by Evan Cudone (5768813)

The <i>rcan-1</i> rearrangement allele decreases expression of <i>rcan-1</i>. by Yuehui Zhao (3146229)

“…The gene with the largest and most significant expression decrease was <i>rcan-1</i>. Red: p<0.01, log₂(Fold Change) > 1. …”

B-RAF inhibitor PLX4720 decreased hERG currents in rhabdomyosarcoma RD cells. by Tatsiana Pakladok (311653)

KPn infection decreases the level of surface exposed phosphatidylserine (PS) and reduces efferocytosis of infected neutrophils. by Christopher N. Jondle (5807657)

Blocking VIP-signaling decreased inflammation and necrosis in the liver and lung of mCMV-infected mice. by Jian-Ming Li (319425)

Decreased proliferation and increased apoptosis in <i>Mab21l2</i> mutant embryos. by Yohei Saito (180130)

“…<p>(A–F) BrdU assay on transverse paraffin sections of E11.5 WT and <i>Mab21l2</i> mutant (−/−) embryos. BrdU staining shows decreased cell proliferation in the trabecular myocardium and compact myocardium (asterisk) of left (F) and right ventricle (E) in <i>Mab21l2</i> mutant (D–F) compared to WT embryos (A–C). …”

HAART does not affect CTLA-4 expression, but significantly decreases CD39 expression in Tregs. by Pietro Presicce (144163)

HAART decreased enhanced expression of cell cycling markers in Tregs from HIV-infected subjects. by Pietro Presicce (144163)

Basal ubiquitination of GlyT2 in neurons decreases when the pool of free monomeric ubiquitin is reduced. by Jaime de Juan-Sanz (386083)

<i>patDp</i>/+ mice display decreased exploratory activity in the open field test. by Kota Tamada (235174)

Decreased survival, splenomegaly, thrombocytopenia and megakaryocyte alterations in SCID-Rasa3^−/− mice. by Patricia Molina-Ortiz (167505)

Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric <i>in silico</i> ROCOCO trial by Daniëlle B. P. Eekers (5560430)

Excision of HIF1α decreases viral reactivation from latency in infected splenocytes in vivo. by Darlah M. López-Rodríguez (8098544)

ApoE3 decreases Rho activity and F-actin stress fibers in human VSMCs. by Bernadette Y. Hsu (753458)

STAT3 inhibitory peptide decreases IL-9 mediated CCL11 transcriptional activity. by Akira Yamasaki (367062)

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”

YTX treatment decreases tumour development in the B16F10 melanoma mouse model. by Araceli Tobío (3545306)